Introduction
The term 'medical genetics' first appears in Lancelot Hogben's book 'Genetic Principles in Medicine and Social Science' (1931) : 'Whatever views one may entertain concerning the urgency of social policies based on genetic assumptions, the urgency of promptitude in developing the machinery of research in medical genetics should not be overlooked by any who have the advancement of pure science at heart.'
1 The term does not appear again in the book, but I feel confident in saying that 'Genetic Principles in Medicine and Social
Science' was the source of inspiration for Madge Thurlow Macklin's writings on the subject of medical genetics. 2 Whilst Macklin neither cites nor references Hogben in her work, she clearly shared a perceived need to, as Hogben put it, 'infiltrate the curriculum of clinical studies' with instruction in human genetics. It is fair to say that Macklin was much more tenacious and proactive than Hogben in her campaigns for human genetics instruction in medicine. 6 At the Third International Eugenics Congress held during August 1932, she declared:
I feel very much like Ulysses when he was steering between Scylla and Charybdis, for on the one hand there is the non-medical advocate of eugenics who may resent my emphasis upon the medical practitioner as the pivotal point in the eugenic programme, and on the other there is the medical practitioner who may object to my suggestion that he needs more education upon the subject of heredity as applied to medicine. My course, though difficult, is nevertheless clear.
3
Macklin went on to write a series of articles on the subject which culminated in 1933 with a sample syllabus for a course in medical genetics. In addition, she produced a massive review article on the role heredity plays in clinical phenomena in which she provides an impressive list of 200 heritable diseases and discusses twin studies, consanguineous marriage, family pedigrees, and statistical techniques. 9 Macklin reasoned that attending to the hereditary components of diagnosis made possible early detection, diagnosis, and commencement of therapies, and was therefore important in terms of preventive medicine. Further to this, being a strong supporter of eugenics, she believed that 'the triumphs of modern preventive medicine' had served to 'throw into stronger relief the problems of human inheritance;' … persons spared from death by infection are kept alive to succumb to their constitutional disorders, so that we find the death rate from many of the degenerative disorders of the circulatory system, from cancer and from diabetes, rising.
10
These ideas all provided grounds for supporting Hogben's entreaty for scientific investigations of the physical basis of inheritance and for teamwork 'on a very large scale' involving the collaboration of geneticists, clinicians, and ethnologists to 'assess the relative importance of nature and nurture in a specified range of conditions' including 'such physical characteristics as growth limits and resistance to disease.' 11 That being said, the contemporary historian Daniel Kevles has shown that fewer than two hundred people published any research in the early Anglo-North American contingent of human geneticists prior to the Second World War. 12 Of these, fewer than fifty published more than once. The situation changed noticeably after the Second World War.
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Formal positions for human geneticists had been created in thirty-one centres in the United States (twenty-five), Canada (four), and England (two) by the end of the 1950s. 13 Comparatively speaking, five surveys, completed over a period of three decades,
show that the proportion of North American medical schools with formal courses in genetics increased from 8.6 per cent in 1953 to 86.5 per cent in 1985. 14 Correspondingly, across the Atlantic, the membership lists of the Genetical Society of Great Britain show a sharp increase in members involved in medical research in the UK after 1959, rising steeply to 1969 when nearly 12 per cent of the 900 members of the Society were working in medicine. 15 The eventual growth and recognition of medical genetics as a service specialism in the UK and North America that occurred after 1970 came about largely as a result of technological innovations in the form of, first, the new laboratory technologies for identifying chromosomal anomalies and genetic metabolic disease, and, second, the advent of regional newborn screening programs and increased use of amniocentesis in prenatal diagnosis. In all of these countries, the intellectual and specialist movements that supported this growth were emergent phenomena, created, split, and reattached to different groups of actors, and reconfigured at least twice over the next four decades. In each instance, new kinds of working relationships appeared; sets of diverse actors in university-hospital settings coalesced into a new collectivity; and, as a collectivity, actors defined and/or redefined occupational roles and work rules. In the first instance, an elite of PhD-and MD-geneticists built career paths through their work in newly established clinical settings for heredity counselling. These individuals established specialised work patterns by combining hospital work and teaching posts. Furthermore, they drew a 5 clientele of patients on the basis of personal reputations for specialised expertise. In the second instance, counselling and laboratory services became standardised and specialised occupational roles and work rules for clinical and laboratory services were established. In the translatory movement from medical segment to medical specialty, the ideological direction of clinical practices conformed to a pattern widely adopted among contemporary medical specialties. As a result, a formal job classification -medical geneticist -became viable as a full-time occupation in medicine in the UK and North
America.
This paper focuses on the structural development of institution-based interest in genetics in Anglo-North American medicine after 1930 concomitantly with an analysis of the changes through which ideas about heredity and the hereditary transmission of diseases in families have passed. Taking into consideration the lag between theoretical and therapeutic capability in the application of new scientific knowledge, I argue that the unfolding relationship between medicine and genetics can best be understood against the background of the shift in emphasis in conceptualisations of recurring patterns of disease in families from 'biological relatedness' to 'related to chromosomes and genes.' I understand the shift in emphasis to represent a bringing together of the organisational ideas of key innovators in science and medicine and I explore the corresponding characteristics of the institutions they built. I do not claim that the changes in conceptualisations represent average 'medical thinking' at the time; they did not. A minority built academic specialty was formed intending to train a new generation of medical specialists in order to reform clinical practice. Accordingly, a key aim of this 6 paper is intended to permit identification of what objects, questions, concepts, methods, and research are properly considered medical and the institutional steps through which a 'genetics-based approach' to medicine became distinguishable and duly recognised.
The historical confluences of heredity and medicine
Historians of medicine studying the topic of heredity normally posit an early or premodern period in which stories were collected about so-called monstrous births in the naturalist tradition of sixteenth-century Europe. 16 What is most noteworthy here, for the purposes of the present study, is the movement from the singularity of legends, anecdotes, and story-telling to the generality of systems of taxonomy supported by case studies that were published and archived. 17 Case studies of morbid haereditarii (heritable disease) recount a range and categories of physical/developmental forms as well as biographical aspects of illness episodes or narratives in time. As particular 'clues' and 'symptoms' took on special roles and significance (e.g., missing or supernumerary limbs, birth marks diminished stature) case studies took on emblematic status. 18 At the same time, the notion of the 'familial taint' lent typicality to the case at hand. It is taken for granted -usually without particular amazement -that the potential energy of the germ plasm accounts for the development of a full-fledged human 8 being out of a fertilized human ovum of microscopic proportions in the short period of nine months. It is not adequately realized, however, that this potential energy is at work throughout a whole lifetime; that the physiologic evolution and involution, the structure and function of the organs, their mutual relation, and the response to various stimuli depend on this potential energy; that deficiencies and abnormalities of this potential energy may be cooperative etiologic factors or the sole cause of diseases; that they account for the vast majority of congenital malformations in man. And this potential energy is just what we may call individual constitution. The great miracle of this potential energy is fully recognized as far as the fetal development is concerned, but the miracle is not over with the moment of birth. 26 Bauer had emigrated via France to the United States after the German annexation of Austria in 1938. 27 Bauer hoped that constitutional medicine could be connected to current work being done in the United States with breeding and experimental genetics.
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At the same time, he acknowledged a certain weakness in such an idea:
One point … should be stressed: constitution is not a physical entity but a panel and plan of the total set-up of the individual personality. Constitution comprises physical and mental traits, visible and invisible characteristics, which may or may not be detectable by all or any of the various methods of physical examination and laboratory work. Constitution is therefore not a measurable entity; but some of its components may be defined in exact figures. 29 The weakness was not lost on critics of constitutional medicine. 
The historical confluences of genetics and medicine
Archibald Garrod's work on 'inborn errors of metabolism' is a likely place to look for early connections between genetics and medicine. 33 Garrod had developed an interest in chemical pathology while working as a physician on the staff of several hospitals in London in the late nineteenth-and early twentieth-centuries. 34 After being appointed as an assistant physician to the outpatients department of the Hospital for Sick Children in Great Ormond Street, he began to write about cases of rare disorders such as alkaptonuria and porphyrinuria which produce different colours in urine. Garrod's initial observations led him to focus on chemical errors in the metabolism which appear as congenital defects that persist throughout life. 35 He went on to interpret the recurrence patterns in families as following Mendel's law of recessive inheritance. 36 For this he received advice and the collegial approbation of William Bateson, an early proponent of Mendelian genetics and founder of the Genetical Society of Great Britain, and Frederick Gowland Hopkins, a chemist who, in 1894, graduated in medicine and taught for four years physiology and toxicology at Guy's Hospital before moving on to Cambridge University. 37 Still, although the links between defective enzymes, disruptions in metabolic pathways, and disease were evident in the contemporary biochemical literature, biochemists were generally unfamiliar with the tenets of Mendel's laws. Equally, geneticists and physicians were unable to link the idea of a genetically-based enzyme deficiency to any concept of genes or of gene action.
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It is important to note that while Garrod was intrigued by the discovery of the metabolic disease phenylketonuria in the 1930s, the association between the disease and genetics was made by others. 39 Moreover, there is evidence that Garrod was more The association of sex-determination with a chromosomal element had been suggested in the early 1890s with Hermann Henking and colleagues in Germany reporting an unpaired 'chromatin-element' that did not pair with the others during meiosis in the wasp Pyrrhocoris. Henking noted that the male wasps possess twentythree chromosomes. Twenty-two of these were observed as active in eleven pairs during spermatogenesis; the twenty-third remained unpaired. 46 Moreover the behaviour of the genetics' which was to be pursued in relation to experimental embryological studies.
52
Alongside this conceptual foundation, the material object of the chromosome was embedded within associated laboratory practices in the fields of cytology and microscopy which would prove invaluable to laboratory medicine. He might be either an M.D. with special training in genetics, or a Ph.D. in human genetics with added training in the special applications of his subject to medical problems. Such a person could be attached to any department in accord with administrative convenience. He could function in several ways: he might teach the course or give the lectures on general principles in the second year. He could be used for integrated teaching in many areas, as for example in the problems of maternal-fetal immunologic incompatibilities, in connection with the teaching of metabolic diseases, anaemia, bone and eye diseases and in other areas.
61
The medical geneticist 'could also have service and research functions.' 62 Thus, a multifaceted role was envisioned. As 'staff geneticist' in a teaching hospital setting would provide advisory services, on the one hand, in family counselling directly with consultants, and, on the other, to practitioners and researchers requiring consultation in cases involving complex genetic problems.
Importantly, there was a wholesale shift in the way genetic counselling was to be conducted and certain irreconcilable differences identified between the ameliorism of the eugenic 'heredity consciousness' and 'preventive ideas of medicine' advocated by Counseling in medical genetics is a most important practical application of the findings of the science of human genetics. It could help almost every family if available to them. We are still in the beginning stages of the development of sound practices in genetic counselling. As long as we do not take ourselves too seriously but instead approach the problems in a light-hearted manner, there will be no danger of the gory excesses committed in the name of eugenics in the past. … … It is the physician who is likely to have a hand in shaping the future evolution of mankind because our reproduction is no longer completely capricious. The desire for a happy family of normal children is one of the strongest human motivations. For the first time in history the physician is able to be of major assistance in achieving the highest of life's goals. If a couple finds that the family is increasing beyond their fondest expectations, he can slow down the flood. In civilized countries responsible parents no longer leave reproduction to the vagaries of chance. The physician officiates at the birth of the child and is the authoritative source of scientific information about reproduction.
65
In this context, non-directive genetic counselling, in effect, was to become a contract for services and the essence of the physician-patient relationship would be transformed from one of status to one of contract. 66 The recommendations of the 1954 AAMC report enjoyed considerable support and further discussion in subsequent surveys and reviews. Three surveys indicate that, rather than an integrated curriculum, genetics instruction increasingly became the preserve of paediatricians and geneticists teaching in independent genetics departments. 67 This issue went on to be described in the surveys and reviews as an interdisciplinary 'problem;' a problem frustrating the larger goal 'that "genetically thinking" becomes an ... it is incumbent on clinicians in all health care disciplines to recognize when health impairment is due, in part or in whole, to a genetic cause. All clinicians must be able to determine whether a given disorder is genetic, possibly genetic, or not genetic, and be able to share that information with the patient or family and refer them, if necessary, to specialists for further assistance. ... Ensuring that a family with a genetic disorder receives genetic counselling is a primary care responsibility, even though the actual genetic counselling may be carried out by a specialist in a secondary or tertiary care facility. 71 
(Emphasis in the original)
It is certainly the case that local associative strategies among medical professionals surrounding specialty formation and the institutionalisation of geneticsbased diagnostic and laboratory services initially emphasised, on the one hand, multidisciplinary task specialisation among service providers working in regional centres and, on the other, more or less continually unfolding internal differentiation among academic health centres, community clinics, consumer and voluntary groups, government agencies, and public health departments. The patterned and the temporal organisation of contemporary genetic health services in the UK and North America nevertheless reflects different levels of interplay between autonomous action and constraining structure in local settings. On the one hand, geneticists entering clinical settings learned to conduct themselves in accordance with the same proscriptions that stem from the diverse histories of service relationships at the particular institutions employing them. Still, geneticists also maintain that, as medical specialists, they provided services in a manner that is similar, if not the same, as others in their specialism around the world. Accordingly, it is important, from an historical standpoint, to distinguish between what are here idealtypically the features of medical genetics in toto and factors affecting the way that specialty services have been delivered locally.
The addition of the new laboratory services for identifying chromosomal anomalies and genetic metabolic disease described in the previous section of this paper contributed significantly to the growth of counselling clinics which, during the 1950s, had developed in an ad hoc and piecemeal fashion. The Canadian case shows how occupational specialisation in the broader field of genetics and medicine underwent remarkable divarication in a relatively short period of time.
Moreover, it shows that the role of the geneticist in medicine evolved to a point where interchangeability between clinical-and laboratory-based functions abated.
Medical genetics in the UK took a more circuitous route. Broadly speaking, the formal structure for the National Health Service 'integrated genetics service' fit well within the regimes of service delivery instituted between 1974 and 1982 when the NHS was reorganised to integrate hospital, community health care and family practitioner services under a unified management structure. By 1982, genetic laboratory services and counselling clinics were to be found in nineteen NHS regions across the UK. 75 The 21 regional genetic centre became the hallmark of British medical genetics, holding regular clinics in the centre and also satellite clinics to which clinicians would be dispatched to see patients in District General Hospitals. A decade later, responsibility for genetic services would devolve from regional administration to conurbations of districts.
The notion of the regional genetics centre that emerged from the 1970s and 1980s combined ideas about the health needs of populations with an omnibus 'genetic approach' to health and illness. In its simplest geographical aspect, regional services consisted of two generalised unit parts: the centre and the adjoining catchment area. The two developed together, each presupposing the other. But while the centre was compact and readily visible, the catchment area was diffuse and difficult of precise observation.
The boundaries of regional genetic services in fact appeared in varying degrees of distinctness at the local level according to the repertoire of policy instruments available, the preferences of the dominant technocratic elites, and the position and power of local bureaucracies to control funding and other kinds of resources. Genetic services, in this context, represent a series of concentric zones around service centres which differ in the degree of attachment of their occupants to the centres, of the frequency of movement of patients or patient information to and from the centres, and in the extent to which contacts with the centres are, on the one hand, direct, involving the movement of individuals, or, on the other, indirect, involving a circulation of information and specimens rather than people.
With regard to the division of labour in the delivery of services in regional genetics centres in both the UK and North America, two broad sets of activities can be 22 discerned that involved the geneticist in the capacity of consultant. The first set falls under a general category of prenatal care in pregnancy and childbirth, and overlaps with the jurisdictional claims of obstetrics and gynaecology. This set of activities can be distinguished from 'general genetics,' which is a catch-all category for clinical activities involving infants, children and adults. As a set of activities unto itself, it can be further divided into three sub-sets. Activities in the first sub-set overlap with the jurisdictional claims of neonatology. This involves the diagnosis and management of congenital anomalies and diseases in newborns. The second sub-set takes up broader paediatric concerns and focuses on the diagnosis and management of genetic conditions in children.
Finally, the third sub-set deals with, on the one hand, the diagnosis of adult-onset diseases and, on the other, screening for carriers of heritable conditions. In this regard, the character of the jurisdictional interface with other specialists (i.e., non-geneticists) shifts paradigmatically depending on whether the patient is a pregnant woman, an infant, a child, or an adult.
It is especially noteworthy that open competition between clinical geneticists and other specialists for jurisdiction over particular kinds of patients and types of disease has gone virtually unheard of. 76 By the turn of the century, clinical interest in applied human genetics expanded to embrace a wider set of service relations as progressively more physicians and allied health personnel from specialty areas other than medical genetics either took over the diagnosis and management of patients in independent clinics or worked jointly with genetic service providers in hybridised clinical units for specific illness groups characterised as 'complex,' 'multifactorial' or 'polygenic.' This would normally be seen from historical and sociological viewpoints as evidence of competing specialist segments and jurisdictional disputes in medicine, i.e., as an encroachment on the medical geneticists' claim to professional jurisdiction over a genetics-based approached to medicine. 77 Correspondingly, a late twentieth-century analysis of primary medical specialties might expect an ideological shift on the part of medical genetics in the direction of de-specialisation in order to accommodate the expanding remit of the genetics-based approach in medicine and changes in the administration of health services marked by deregulation and a transition away from centralised styles of governance. … the main issue is ... that actions are being taken with respect to non-negotiated limits imposed or signalled by one side and agreed to directly by the other. These kinds of silent bargains, then, would seem to pertain to agreements that are not much brought into explicit discussion and that represent limits within which negotiation can go on. Sometimes .... they go on in support of the limits, or they temporarily stretch the limits. 81 
(Emphasis in original)
An argument follows that goes something like this: In the first place, the jurisdictional interface between medical genetics and other specialties has been 
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The terms 'molecular genetics' and 'molecular geneticist' appeared soon thereafter. London for the establishment of a strong centralised bureaucracy at the national level to oversee the existing network of regional DNA laboratories. 86 None of the regional genetics centres provided the full range of tests available. Moreover, there was no strategic overview to ensure the availability of effective testing services and to avoid unnecessary duplication of service provision. The differences between testing facilities were made up for largely by informal inter-centre service arrangements largely sustained by local interests. DNA testing had not become routine by this time, automation and kitbased technologies had yet to make a major impact on laboratory work. Most of the raw materials needed to do testing (e.g., DNA probes, restriction enzymes and gels for electrophoresis) could all be made in the laboratory, and with no expensive instrumentation, set-up costs for laboratories were low. There was, nonetheless, constant change and shifting ground within the technology of molecular diagnostics which meant that laboratory staff had to remain on top of advancements in basic research. subsequently outlined a commitment on the part of government of more than £18 million to upgrade NHS genetics laboratory facilities and £3.5 million to increase the workforce in the laboratories. 89 Consequently, two National Genetics Reference Laboratories were set up at Manchester and Salisbury to research and evaluate new technologies and ways of testing, offer training, disseminate information on best practice, and expand existing quality assurance programs.
Conclusions
When we consider 'medical genetics' as a historical subject, we find that its distinctiveness from other medical specialisms is a matter for debate and we do not seem to be dealing with a single set of techniques and methods. The story of medical genetics is therefore not a linear history of ideas, although ideas are at its centre. One can note a reductionist manoeuvre to unify and subsume (i.e., reduce), on the one hand, all that has been observed in clinical accounts of episodes of familial illness and, on the other, all that has been observed about cells, chromosomes, genes, proteins, and enzymes in genetic Specialist status arose from the person, and not the task. Using Thompson's nomenclature, there was high personal specialization in the medical genetics prior to specialty formation, but only one operative role, i.e., the geneticist in the teaching hospital setting. In the translatory movement from medical segment to medical specialty, the ideological direction of clinical practices conformed to a pattern widely adopted among contemporary medical specialties. As a result, a formal job classificationmedical or clinical geneticist -became viable as a full-time occupation in medicine.
'Task specialisation' followed with counselling and laboratory services becoming standardised and specialised occupational roles and work rules for clinical and laboratory services being institutionalised across networks of regional genetic service centres in the 1970s.
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As a final point, the paper indicates that, of late, networked innovation and the circulation of standards of laboratory and clinical practice are diffusing horizontally across a wide variety of specialty areas as the advantages the genetics-based approach are applied in different clinical settings and specialist activities other than medical genetics.
This, I would like to suggest, represents a new development in what I have described as a bifurcated ideological construct that has shaped and informed the means of organising a genetics-based approach to medicine. The construct stipulates, on the one hand, that the mandate of medical genetics is to add a new set of medical procedures to the clinical repertoire of all health service providers. On the other hand, the mandate also provides for a class of specialists (i.e., medical geneticists) who will be available for consultation and assistance to other health service providers in pursuit of offering a genetics-based approach to medicine. The new development reinforces the idea that medical genetics is inclusive as opposed to exclusive in the occupational hub culture of medicine.
